Login

Mr. David Sin is the Co-Founder, Group President, and Deputy Chairman of the Board of Fullerton Health, and an alumnus of The Chinese High School. 00:10:00

Share On Facebook Share On Twitter

Chang Ching Wu CEO. Chief Executive Officer

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jeff Ackert, BSc.President, CEO & Director of Cascade Copper Corp
00:10:00
eMobility Expo World Congress: Revolutionizing Transportation with Green Hydrogen | Dr. Sebastian C. Schulte - CEO of DEUTZ AG
00:10:00
redefine what venture capital is capable of by prioritizing a new outcome|Brian Dixon,Managing Partner,Kapor Capital
00:10:00
Single founder is better than two or more co founder|Vaibhav Domkundwar,CEO & Founder,Better Capital
00:10:00
Exploring Healthcare Investment Opportunities in the UK: Insights from Portfolio Analysis and Market Fundamentals|CEO,Aedifica NV
00:10:00
Loupe Cara: Leading Diamond Producer Unveils Expansion Plans and Innovation at One-to-One Mining Investment Conference
00:10:00
Interview with Hans Wallenstam, CEO of Wallenstam | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
ITN Features Petra Financial's Innovative Solutions | Petra Financial
00:10:00
Pledgecamp is a secure and transparent blockchain-powered framework for crowdfunding|Alireza Masrour,General Partner,Plug N Play Ventures
00:10:00
Rebuilding with Heart: Patricia Poppe, CEO of PG&E, on Leading with Love, Joy in the Workplace, and Corporate America’s Challenges
00:10:00
Antony Beckmand Explores Ertelien’s Historic Drilling Program in Latest Kuniko Interview | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Peak Resources Advances Rare Earth Project in Tanzania, Highlights Strategic Plans at One-to-One Mining Conference

© 2017 - Neuhu+